Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 178 (8), 1255-1265

Oral Vitamin A Supplementation in Very Low Birth Weight Neonates: A Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Oral Vitamin A Supplementation in Very Low Birth Weight Neonates: A Randomized Controlled Trial

Sriparna Basu et al. Eur J Pediatr.

Erratum in

Abstract

This randomized double-blind placebo-controlled trial evaluated the effects of early postnatal oral vitamin A supplementation (VAS) in 196 inborn very-low birth weight (VLBW) infants requiring respiratory support at 24 h of age. Eligible infants were randomized to receive aqueous syrup of vitamin A (10,000 IU of retinol/dose; n = 98) or placebo (n = 98) on alternate days for 28 days. Primary outcome variable was composite incidence of all-cause mortality and/or oxygen requirement for 28 days. Secondary outcome variables were safety/tolerability of VAS, serum retinol concentration at recruitment and day 28, duration of oxygen requirement and respiratory support and incidences of complications. On intention-to-treat analysis, composite incidence of all-cause mortality and oxygen requirement for 28 days was significantly lower in vitamin A group (relative risk (95% confidence interval), 0.440 (0.229-0.844); p < 0.05, number needed to benefit, 7). Requirement and duration of oxygen supplementation and non-invasive respiratory support, incidences of late-onset sepsis, patent ductus arteriosus, and duration of hospital stay were also significantly lower in vitamin A group. Serum retinol concentration improved significantly after VAS. No major adverse effect was observed.Conclusions: Early postnatal oral VAS was associated with better composite outcome of all-cause mortality and oxygen requirement without any major adverse effects.Clinical Trial Registration: Clinical Trials Registry of India (CTRI/2017/03/008131). What is Known: • Postnatal intramuscular vitamin A supplementation improves the survival, respiratory outcome and other morbidities in very low birth weight neonates without major adverse effects. • Limited studies on oral vitamin A supplementation did not document substantial benefits. What is New: • Early postnatal alternate-day oral vitamin A supplementation at the dose of 10,000 IU/dose for 28 days improves the composite outcome of death and oxygen requirement in very low birth weight neonates with respiratory distress • No major adverse effects were documented.

Keywords: Neonate; Oral; Very low birth weight; Vitamin A supplementation.

Similar articles

See all similar articles

Cited by 3 articles

References

    1. N Engl J Med. 1999 Jun 24;340(25):1962-8 - PubMed
    1. Arch Dis Child Fetal Neonatal Ed. 2001 Jan;84(1):F9-F13 - PubMed
    1. Pediatr Res. 2001 Jun;49(6):744-6 - PubMed
    1. Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9 - PubMed
    1. J Pediatr. 2003 Jun;142(6):656-61 - PubMed

Publication types

MeSH terms

Grant support

LinkOut - more resources

Feedback